6 results match your criteria: "Duke Margolis Health Policy Center[Affiliation]"
Am J Geriatr Psychiatry
September 2024
Department of Population Health Sciences (LZ, MSB, SNH), Duke University School of Medicine, Durham, NC; Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT) (SW, MSB, SNH), Durham VA Medical Center, Durham, NC; Division of Geriatrics (SNH), Duke University School of Medicine, Durham, NC.
Objectives: Adults with dementia are frequently prescribed antipsychotic medications despite concerns that risks outweigh benefits. Understanding conditions where antipsychotics are initially prescribed, such as hospitalization, may offer insights into reducing inappropriate use.
Design, Setting, Participants: Retrospective cohort study of community-dwelling veterans with dementia aged ≥68 with VA hospitalizations in 2014, using Veterans Health Administration (VA) and Medicare data.
Health Policy Plan
May 2024
Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham Veterans Affairs Health Care System, 508 Fulton Street, Durham, NC 27705, United States.
Providers have intended and unintended responses to payment reforms, such as China's new case-based payment system, i.e. Diagnosis-Intervention Packet (DIP) under global budget, that classified patients based on the combination of principal diagnosis and procedures.
View Article and Find Full Text PDFJ Am Geriatr Soc
March 2024
Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, Rhode Island, USA.
Background: The Imaging Dementia Evidence for Amyloid Scanning (IDEAS) study reports that amyloid PET scans help providers diagnose and manage Alzheimer's disease and related dementias (ADRD). Using CARE-IDEAS, an IDEAS supplemental study, we examined the association between amyloid PET scan result (elevated or non-elevated amyloid), patient characteristics, and participant healthcare utilization.
Methods: We linked respondents in CARE-IDEAS study to their Medicare fee-for-service records (n = 1333).
J Gen Intern Med
February 2024
Duke Margolis Health Policy Center, Washington, USA.
When the Medicare Part D benefit was constructed, drugs for weight loss were explicitly excluded from coverage, as the limited effectiveness and unfavorable safety profile of medications available at the time failed to justify coverage of drugs perceived to be used for cosmetic purposes. In recent years, drugs activating the glucagon-like peptide-1 receptor (GLP-1R) pathway have proved to achieve significant reductions in body weight with a favorable safety profile. The effectiveness of GLP-1R agonists in reducing weight and improving the metabolic profile warrants the reconsideration of the historical exclusion of weight loss drugs from Part D coverage.
View Article and Find Full Text PDFPsychiatr Serv
June 2017
Dr. Brown is with the Department of Psychiatry and Behavioral Health and with the Department of Medicine, Duke University School of Medicine, Durham, North Carolina ( ), where Dr. Hunter is affiliated. Dr. Hesson is with the College of Human Medicine, Michigan State University, East Lansing. Mr. Davis, Ms. Kirby, and Dr. Ubel are with the Duke-Margolis Health Policy Center and with the Fuqua School of Business, Duke University, both in Durham. Mr. Barnett and Mr. Byelmac are with Verilogue Inc., Horsham, Pennsylvania.
Objective: High out-of-pocket expenses for medical treatment have been associated with worse quality of life, decreased treatment adherence, and increased risk of adverse health outcomes. Treatment of depression potentially has high out-of-pocket expenses. Limited data characterize psychiatrist-patient conversations about health care costs.
View Article and Find Full Text PDFPer Med
September 2016
Duke-Margolis Health Policy Center, Durham, NC 27708, USA.
Aim: Identify the behavioral challenges to the use of genome sequencing (GS) in a clinical setting.
Materials & Methods: We observed how general internists and nongenetic specialists delivered GS results to patients enrolled in the MedSeq Project. Using transcripts of such disclosure interactions, we made qualitative observations of communication behaviors that could limit the usefulness of GS results until reaching the point of thematic saturation.